CDSCO partially revises the timings for hearing against banning of 349 fixed dose combinations

CDSCO partially revises the timings for hearing against banning of 349 fixed dose combinations

CDSCO partially revises the timings for hearing against banning of 349 fixed dose combinations

by Lexplosion | Jun 13, 2018 | OPS, Pharmaceuticals, states

The Central Drugs Standard Control Organization (“CDSCO”) has partially revised the timings for... Read More

CDSCO issues a list of spurious, adulterated, misbranded, or not of standard quality drugs and devices for the month of April, 2018

CDSCO issues a list of spurious, adulterated, misbranded, or not of standard quality drugs and devices for the month of April, 2018

by Lexplosion | Jun 6, 2018 | Healthcare, OPS, states

In the Safety Alert section of its official website, Central Drugs Standard Control... Read More

CDSCO takes steps to prevent illegal manufacturing, sale and distribution of Oxytocin

CDSCO takes steps to prevent illegal manufacturing, sale and distribution of Oxytocin

by Lexplosion | May 28, 2018 | Healthcare, OPS, Pharmaceuticals, states

An Office Memorandum dated 21st May, 2018, has been issued by the Central Drugs Standard Control... Read More

CDSCO announces list of Notified Bodies under the Medical Devices Rules, 2017

CDSCO announces list of Notified Bodies under the Medical Devices Rules, 2017

by Lexplosion | May 9, 2018 | OPS, Pharmaceuticals, states

The Central Drugs Standard Control Organization (“CDSCO”), in a notice dated 4th May, 2018, has... Read More

CDSCO issues a list of spurious, adulterated, misbranded, or not of standard quality drugs and devices

CDSCO issues a list of spurious, adulterated, misbranded, or not of standard quality drugs and devices

by Lexplosion | Apr 26, 2018 | OPS, Pharmaceuticals, states

In the Safety Alert section of its official website, Central Drugs Standard Control... Read More

« Older Entries

Next Entries »